The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease

Author(s): Matiullah Naqibullah, Maiken J. Calberg, Erik Kjoller

Journal Name: Current Cardiology Reviews

Volume 3 , Issue 2 , 2007

Become EABM
Become Reviewer
Call for Editor


Uric acid is produced by the degradation of purines, a process catalysed by xanthine oxidase, which is also responsible for the production of toxic free radicals. This provides a central link to the association between serum uric acid and myocardial ischemia, myocardial dysfunction and also non-cardiac dysfunction in patients with heart disease, mainly due to an impaired peripheral circulation. Uric acid can thus be considered a marker for pathophysiological mechanisms in patients with heart disease, and thus an explanation for S-uric acids prognostic importance. Inhibition of xanthine oxidase by allopurinol may possibly be used as a therapy for patients with heart disease in the future.

Keywords: Uric acid, xanthine dehydrogenase, cardiovascular disease, myocardial ischemia, endothelium, heart failure, ventricular dysfunction, allopurinol, metabolism, pathophysiological mechanism

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [99 - 103]
Pages: 5
DOI: 10.2174/157340307780618406
Price: $65

Article Metrics

PDF: 2